Insider · CIK 0001327433

Boyd Thomas A

Reports to the SEC for 1 company · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001327433

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-07-01	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Sr. VP, Product Dev.	AAward	+30K sh	—	—	30,000
2010-07-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+2,675 sh	$4.44	+$11.9K	39,539
2010-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,299 sh	—	—	2,299
2010-07-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−2,402 sh	$5.35	−$12.9K	37,137
2010-07-01	PROGENICS PHARMACEUTICALS INCA Award	Sr. VP, Product Dev.	AAward	+10K sh	—	—	47,137
2010-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−2,675 sh	—	—	0
2010-06-22	PROGENICS PHARMACEUTICALS INCS Sale	Sr. VP, Product Dev.	SSale	−2,409 sh	$5.74	−$13.8K	36,625
2010-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,228 sh	—	—	2,228
2010-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−2,621 sh	—	—	0
2010-04-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−2,385 sh	$5.36	−$12.8K	39,034
2010-04-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+2,621 sh	$4.56	+$11.9K	41,419
2010-04-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+2,621 sh	$4.56	+$11.9K	41,419
2010-04-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−2,385 sh	$5.36	−$12.8K	39,034
2010-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−2,621 sh	—	—	0
2010-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,228 sh	—	—	2,228
2010-01-04	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+7,630 sh	—	—	7,630
2010-01-04	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−3,147 sh	—	—	0
2010-01-04	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+3,147 sh	$3.78	+$11.9K	41,455
2010-01-04	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−2,864 sh	$4.45	−$12.7K	38,591
2009-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−2,666 sh	—	—	0
2009-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,266 sh	—	—	2,266
2009-10-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−2,426 sh	$5.01	−$12.2K	38,060
2009-10-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+2,666 sh	$4.26	+$11.4K	40,486
2009-07-01	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Sr. VP, Product Dev.	AAward	+50K sh	—	—	50,000
2009-07-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+7,738 sh	$5.33	+$41.2K	44,651
2009-07-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−7,041 sh	$5.33	−$37.5K	37,610
2009-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,306 sh	—	—	2,306
2009-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−7,738 sh	—	—	0
2009-06-23	PROGENICS PHARMACEUTICALS INCS Sale	Sr. VP, Product Dev.	SSale	−2,000 sh	$4.73	−$9,468	36,699
2009-04-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−1,929 sh	$6.65	−$12.8K	36,579
2009-04-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+2,120 sh	$5.65	+$12K	38,699
2009-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−2,120 sh	—	—	0
2009-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+1,802 sh	—	—	1,802
2009-01-02	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−1,233 sh	$10.74	−$13.2K	38,340
2009-01-02	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+1,355 sh	$9.13	+$12.4K	39,573
2009-01-02	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−1,355 sh	—	—	0
2009-01-02	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,364 sh	—	—	2,364
2008-06-23	PROGENICS PHARMACEUTICALS INCD Disposition to Issuer	Sr. VP, Product Dev.	DDisposition to Issuer	−2,700 sh	$17.00	−$45.9K	29,205
2008-01-02	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+2,065 sh	—	—	2,065
2008-01-02	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−692 sh	—	—	0
2008-01-02	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+692 sh	$15.33	+$10.6K	37,194
2008-01-02	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−630 sh	$18.03	−$11.4K	36,564
2007-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	−2,029 sh	—	—	0
2007-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Sr. VP, Product Dev.	AAward	+481 sh	—	—	481
2007-10-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+2,029 sh	$19.03	+$38.6K	38,288
2007-10-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Sr. VP, Product Dev.	FTax Payment	−1,847 sh	$22.39	−$41.4K	36,441
2007-08-15	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+500 sh	$13.63	+$6,812.5	36,709
2007-08-15	PROGENICS PHARMACEUTICALS INCS Sale	Sr. VP, Product Dev.	SSale	−500 sh	$22.85	−$11.4K	36,209
2007-08-15	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP, Product Dev.	MExercise/Conversion	+1,500 sh	$17.19	+$25.8K	37,709
2007-08-15	PROGENICS PHARMACEUTICALS INCS Sale	Sr. VP, Product Dev.	SSale	−1,500 sh	$22.92	−$34.4K	36,209

Recent filings

Accepted (ET)
Jul 64
Boyd Thomas A0001441844-10-000052
SEC(opens sec.gov)
Jun 244
Boyd Thomas A0001441844-10-000038
SEC(opens sec.gov)
Apr 54
Boyd Thomas A0001441844-10-000022
SEC(opens sec.gov)
Apr 54
Boyd Thomas A0001441844-10-000021
SEC(opens sec.gov)
Jan 64
Boyd Thomas A0001441844-10-000008
SEC(opens sec.gov)
Oct 54
Boyd Thomas A0001447348-09-000014
SEC(opens sec.gov)

Companies

PROGENICS PHARMACEUTICALS INCSr. VP, Product Dev.

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591